Noni para Hiperglucemia / Desequilibrio metabólico
Morinda citrifolia — 8 estudios científicos revisados
Moderate¿Sirve Noni para hiperglucemia / desequilibrio metabólico?
Los polisacáridos degradados del jugo de noni pueden mejorar el consumo de glucosa mediante la activación de la vía de señalización PI3K/AKT-Nrf2-GSK3β [PMID 40941105].
Compuestos activos involucrados: xeronina, escopoletina, damnacantal, iridoides, Alcaloides, Flavonoides, Lignanos, Quercetina, Rutina, Terpeno, Terpenos
Evidencia Científica
Los siguientes estudios han investigado la relación entre Noni y hiperglucemia / desequilibrio metabólico:
A therapeutic approach of LC-MS characterised MFER-Mc against alcohol and NDEA induced hepatocellular carcinoma activity through LXR-α, LXR-β and HMG-CoA pathway: an in-silico, in-vitro and in-vivo study.
Ethanol was previously classified as a co-carcinogen or tumour promoter, based on early animal studies. Ethanol may also contribute to cancer development indirectly by serving as a solvent for chemical constituents found in tobacco smoke, fried meals that contain N-nitrosodiethylamine (NDEA), led to increased production of reactive oxygen species (ROS), inflammation, fibrosis, enhanced cell proliferation, and the development of hepatocellular carcinoma (HCC). Approximately 70% of anticancer agents are derived from plant-based sources. This study was designed under in silico, in vitro, and in v
PubMed: 41455855Antimicrobial and antibiofilm actions of iridoids: a comprehensive mechanistic review.
The intensive use of antibiotics resulted in the development of resistance, posing a significant global threat to human health. Natural products have garnered significant attention in modern drug discovery and development. Utilizing natural compounds and extracts, either alone or in combination with conventional antimicrobial drugs, could be a significant development in overcoming pathogen resistance mechanisms. Among these natural compounds, iridoids exhibited diverse biological activities, such as anti-inflammatory, antioxidant, anticancer, antidiabetic, antimicrobial, and neuroprotective pr
PubMed: 41765944Morinda citrifolia L. (noni) and its potential in the management of systemic metabolic disorder (SMD).
Morinda citrifolia L. (noni) is a tropical plant containing over 200 phytochemicals, including terpenoids, anthraquinones, coumarins, flavonoids, lignans, and polysaccharides, with demonstrated biological activities such as antioxidant, anti-inflammatory, hypoglycaemic, hepatoprotective, and cardioprotective effects. Studies indicate that noni and its bioactive components, such as scopoletin, quercetin, rutin, ursolic acid, and polysaccharides, exert beneficial effects on systemic metabolic disorder (SMD). SMD is a complex syndrome involving multi-organ metabolic dysregulation, characterized b
PubMed: 41243483Degraded Polysaccharides from Noni (Morinda citrifolia L.) juice Mitigate Glucose Metabolism Disorders by Regulating PI3K/AKT-Nrf2-GSK3β Signaling Pathways in HepG2 Cells.
Noni juice polysaccharides demonstrate promising hypoglycemic activity, but their high molecular weight restricts bioavailability. This study established a controlled degradation approach to optimize the functional properties of Noni juice polysaccharides. Molecular characterization demonstrated that the degraded Noni juice polysaccharides (DNJPs, Mw 191.8 kDa) retained the core monosaccharide composition, while exhibiting enhanced solubility. In vitro experiments with insulin-resistant HepG2 cells showed that DNJPs (0.5-2 mg/mL) significantly enhanced glucose consumption (p < 0.01) and mitiga
PubMed: 40941105Morinda citrifolia Linn. (Noni) and Its Potential in Obesity-Related Metabolic Dysfunction.
Cultural and economic shifts in the early 19th century led to the rapid development of companies that made good profits from technologically-produced commodities. In this way, some habits changed in society, such as the overconsumption of processed and micronutrient-poor foods and devices that gave rise to a sedentary lifestyle. These factors influenced host-microbiome interactions which, in turn, mediated the etiopathogenesis of "new-era" disorders and diseases, which are closely related, such as obesity, type 2 diabetes mellitus, non-alcoholic fatty liver disease, hypertension, and inflammat
PubMed: 28587078Seguridad y Precauciones
La seguridad del uso de Noni (Morinda citrifolia) requiere una supervisión cuidadosa debido a su complejidad bioquímica y la falta de estandarización en los productos comerciales. En cuanto al embarazo y la lactancia, no existe evidencia clínica suficiente que garantice la inocuidad del consumo de noni en mujeres gestantes o lactantes; por lo tanto, su uso está contraindicado en estas etapas para evitar riesgos potenciales al desarrollo fetal o al lactante, dado que los compuestos como los iridoides y alcaloides pueden atravesar barreras biológicas. Para la población infantil, especialmente niños menores de 12 años, se recomienda evitar su administración debido a la ausencia de estudios de toxicidad pediátrica y la incertidumbre sobre el impacto en el desarrollo hormonal y metabólico en organismos en crecimiento. En el ámbito de las interacciones farmacológicas, el noni presenta riesgos significativos. Se debe evitar la combinación con la fenitoína (un anticonvulsivo de estrecho margen terapéutico), ya que estudios indican que el noni puede reducir las concentraciones plasmáticas de este fármaco a niveles subterapéuticos, lo que aumenta el riesgo de crisis convulsivas [PMID 41560756]. Asimismo, debido a su potencial efecto sobre la glucosa y la vía PI3K/AKT, su uso conjunto con fármacos para la diabetes como la metformina podría potenciar excesivamente la hipoglucemia.
Perfil completo: Ver todos los usos y evidencia de Noni →